🔗 Share this article

The prestigious award in Physiology or Medicine was granted for transformative findings that clarify how the immune system targets harmful infections while sparing the body's own cells.

A trio of esteemed scientists—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this honor.

The work identified specialized "sentinels" within the defense system that remove malfunctioning defense cells that could harming the organism.

The findings are now enabling new treatments for immune disorders and cancer.

The laureates will share a monetary award worth 11m SEK.

Crucial Findings

"Their research has been decisive for comprehending how the body's defenses functions and the reason we don't all develop serious self-attack conditions," stated the head of the Nobel Committee.

This team's research explain a core question: In what way does the defense system defend us from numerous invaders while keeping our healthy cells intact?

The immune system uses white blood cells that scan for indicators of infection, even viruses and germs it has not met before.

These cells employ detectors—called recognition units—that are produced randomly in countless variations.

This gives the defense network the ability to combat a broad range of invaders, but the unpredictability of the mechanism inevitably creates immune cells that can target the body.

Security Guards of the Immune System

Researchers previously knew that some of these harmful defense cells were destroyed in the thymus—where white blood cells develop.

This year's award recognizes the identification of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to neutralize other immune cells that assault the body's own tissues.

It is known that this process fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel added, "The discoveries have established a novel area of research and spurred the creation of new treatments, for instance for cancer and immune disorders."

Regarding cancer, regulatory T-cells prevent the body from fighting the growth, so studies are focused on reducing their numbers.

For autoimmune diseases, trials are testing increasing T-reg cells so the organism is no longer being harmed. A similar approach could also be effective in minimizing the chances of organ transplant failure.

Innovative Studies

Prof Shimon Sakaguchi, of a Japanese institution, conducted tests on mice that had their immune gland removed, leading to autoimmune disease.

He demonstrated that injecting defense cells from other animals could stop the disease—implying there was a system for preventing defenders from attacking the host.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in mice and humans that led to the discovery of a gene critical for the way T-regs operate.

"The pioneering research has uncovered how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," said a leading biological science expert.

"The work is a remarkable example of how basic physiological study can have broad consequences for public health."